Viatris (VTRS) Return on Capital Employed (2020 - 2026)
Viatris (VTRS) posted quarterly Return on Capital Employed of 0.46% for Q1 2026, up 944.0% year-over-year from 0.04% in Q1 2025, and up 105.28% quarter-over-quarter from 8.74% in Q4 2025.
Viatris (VTRS) Return on Capital Employed (2020 - 2026) Analysis & Trends
Viatris' Return on Capital Employed history runs 7 years deep, the most recent figure standing at 0.46% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 944.0% year-over-year to 0.46%; the TTM figure through Mar 2026 stood at 0.46% (up 944.0% YoY), while the FY2025 annual figure was 8.26%, down 828.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 0.46%, up from 8.74% in the prior quarter.
- The five-year high for Return on Capital Employed was 4.01% in Q3 2022, with the low at 8.98% in Q1 2025.
- The 5-year median for Return on Capital Employed is 1.43% (2024), against an average of 0.6%.
- The sharpest annual moves came in 2025 and 2026: Return on Capital Employed sank 1041 bps in 2025, then surged 944 bps in 2026.
- Viatris' Return on Capital Employed stood at 3.79% in 2022, then sank by 50 bps to 1.89% in 2023, then slumped by 99 bps to 0.03% in 2024, then slumped by 32427 bps to 8.74% in 2025, then surged by 105 bps to 0.46% in 2026.
- Business Quant data shows VTRS's Return on Capital Employed at 0.46% in Q1 2026, 8.74% in Q4 2025, and 8.6% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 3.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.29% |
| Mar 31, 2026 | 0.46% |
| Dec 31, 2025 | -8.74% |
| Sep 30, 2025 | -8.60% |
| Jun 30, 2025 | -8.31% |
| Mar 31, 2025 | -8.98% |
| Dec 31, 2024 | 0.03% |
| Sep 30, 2024 | -0.71% |
| Jun 30, 2024 | -0.10% |
| Mar 31, 2024 | 1.43% |
| Dec 31, 2023 | 1.89% |
| Sep 30, 2023 | 2.43% |
| Jun 30, 2023 | 2.66% |
| Mar 31, 2023 | 3.00% |
| Dec 31, 2022 | 3.79% |
| Sep 30, 2022 | 4.01% |
| Jun 30, 2022 | 3.44% |
| Mar 31, 2022 | 2.11% |
| Dec 31, 2021 | -0.07% |
| Sep 30, 2021 | -1.78% |